Topics

ViiV unveils emotional challenges related to HIV ART treatment

06:00 EDT 4 Oct 2019 | Pharmaceutical Technology

GSK’s ViiV Healthcare has presented results from its Positive Perspectives study examining the emotional challenges and burden of human immunodeficiency...
Read More...

The post ViiV unveils emotional challenges related to HIV ART treatment appeared first on Pharmaceutical Technology.

Original Article: ViiV unveils emotional challenges related to HIV ART treatment

NEXT ARTICLE

More From BioPortfolio on "ViiV unveils emotional challenges related to HIV ART treatment"

Quick Search

Relevant Topics

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...